Hospitalization and discharge education of emergency department patients with hypoglycemia

Diabetes Educator

Volumn 34, Issue 4, 2008, Pages 683-691

  Ginde, Adit A ^a,b   Pallin, Daniel J ^c   Camargo Jr , Carlos A ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; EMERGENCY HEALTH SERVICE; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPOGLYCEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; RETROSPECTIVE STUDY;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES;

EID: 47649090420     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721708321022     Document Type: Article

References (28)

1. Gonder-Frederick LA, Clarke WL, Cox DJ The emotional, social, and behavioral implications of insulin-induced hypoglycemia. Semin Clin Neuropsychiatry. 1997 ; 2: 57-65.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 ; 329: 977-986.
3. The United Kingdom Prospective Diabetes Study Research Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998 ; 352: 837-853.
4. The United Kingdom Prospective Diabetes Study Research Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet. 1998 ; 352: 854-865.
5. Cryer PE Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002 ; 45: 937-948.
6. MacLeod KM, Hepburn DA, Frier BM Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med. 1993 ; 10: 238-245.
7. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999 ; 16: 466-471.
8. DCCT Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997 ; 46 ; 271-286.
9. Bell DS, Cutter G. Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetes. South Med J. 1994 ; 87: 616-620.
10. Holstein A., Plaschke A., Egberts EH Incidence and costs of severe hypoglycemia. Diabetes Care. 2002 ; 25: 2109.
11. The International Classification of Diseases, 9th revision, Clinical Modification. 5 th ed. Salt Lake City, Utah: Medicode ; 1997.
12. Johnson ES, Koepsell TD, Reiber G., Stergachis A., Platt R. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002 ; 55: 253-259.
13. Shorr RI, Ray WA, Daugherty JR, Griffin MR Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997 ; 15: 1681-1687.
14. Herings RMC, de Boer A., Stricker BHCh, Leufkens HGM, Porsuis A. Hypoglycemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995 ; 345: 1195-1198.
15. Morris AD, Boyle DIR, McMahon AD, et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care. 1997 ; 20: 1363-1367.
16. Shorr RI, Ray WA, Daugherty JR, Griffin MR Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA. 1997 ; 278: 40-43.
17. Ginde AA, Blanc PB, Lieberman RM, Camargo CA Jr. Validation of ICD-9 coding to identify emergency department patients with hypoglycemia. BMC Endocr Disord. 2008 ; 8: 4.
18. American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005 ; 28: 1245-1249.
19. Brackenridge A., Wallbank H., Lawrenson RA, Russell-Jones D. Emergency management of diabetes and hypoglycaemia. Emerg Med J. 2006 ; 23: 183-185.
20. Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med. 2001 ; 38: 68-78.
21. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003 ; 26: 1902-1912.
22. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care. 2007 ; 30: S4 - S41.
23. Nordfeldt S., Johansson C., Carlsson E., Hammersjo JA Persistent effects of a pedagogical device targeted at prevention of severe hypoglycaemia: a randomized controlled study. Acta Paediatr. 2005 ; 94: 1395-1401.
24. Segel SA, Paramore DS, Cryer PE Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002 ; 51: 724-744.
25. Dagogo-Jack SE, Craft S., Cryer PE Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest. 1993 ; 91: 819-828.
26. Fanelli C., Pampanelli S., Epifano L., et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia following institution of rational intensive insulin therapy in IDDM. Diabetologia. 1994 ; 37: 1265-1276.
27. Cranston I., Lomas J., Maran A., Macdonald I., Amiel SA Restoration of hypoglycaemia awareness in patients with long-duration insulin dependent diabetes. Lancet. 1994 ; 344: 283-287.
28. Dagogo-Jack S., Rattarasarn C., Cryer PE Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes. 1994 ; 43: 1426-1434.